<?xml version="1.0" encoding="UTF-8"?>
<rss version="2.0" xmlns:atom="http://www.w3.org/2005/Atom">
  <channel>
    <title>Eckert &amp; Ziegler Strahlen- Und Medizintechnik Ag — News on 6ix</title>
    <link>https://6ix.com/company/eckert-and-ziegler-strahlen-und-medizintechnik-ag</link>
    <description>Latest news and press releases for Eckert &amp; Ziegler Strahlen- Und Medizintechnik Ag on 6ix.</description>
    <language>en-us</language>
    <lastBuildDate>Thu, 26 Feb 2026 06:00:00 GMT</lastBuildDate>
    <generator>6ix RSS</generator>
    <atom:link href="https://6ix.com/rss/company/eckert-and-ziegler-strahlen-und-medizintechnik-ag" rel="self" type="application/rss+xml" />
    <image>
      <url>https://6ix-events-pro.s3.amazonaws.com/6ixvideo/logos/org-logo6836043578dffbe2df135693.webp</url>
      <title>Eckert &amp; Ziegler Strahlen- Und Medizintechnik Ag</title>
      <link>https://6ix.com/company/eckert-and-ziegler-strahlen-und-medizintechnik-ag</link>
    </image>
    <item>
      <title>Molecular Partners Signs Development Agreement with Eckert &amp; Ziegler for Targeted Alpha Radiotherapeutics</title>
      <link>https://6ix.com/company/eckert-and-ziegler-strahlen-und-medizintechnik-ag/news/molecular-partners-signs-development-agreement-with-eckert-and-ziegler-for-targeted-alpha-radiotherapeutics</link>
      <guid isPermaLink="true">https://6ix.com/company/eckert-and-ziegler-strahlen-und-medizintechnik-ag/news/molecular-partners-signs-development-agreement-with-eckert-and-ziegler-for-targeted-alpha-radiotherapeutics</guid>
      <pubDate>Thu, 26 Feb 2026 06:00:00 GMT</pubDate>
      <description>Partnership with leading nuclear medicine specialist enables advancing pipeline of wholly-owned Radio-DARPin therapeutics for imaging and therapeutic radio-isotopes, including Actinium-225 (225Ac)ZURICH-SCHLIEREN, Switzerland and CONCORD, Mass., Feb. 26, 2026 (GLOBE NEWSWIRE) -- Molecular Partners AG (SIX: MOLN; NASDAQ: MOLN), a clinical-stage biotech company developing a novel class of custom-built protein drugs known as DARPin therapeutics (“Molecular Partners” or the “Company”), today announc</description>
    </item>
    <item>
      <title>Eckert &amp; Ziegler to Participate in the 44th Annual J.P. Morgan Healthcare Conference</title>
      <link>https://6ix.com/company/eckert-and-ziegler-strahlen-und-medizintechnik-ag/news/eckert-and-ziegler-to-participate-in-the-44th-annual-jp-morgan-healthcare-conference</link>
      <guid isPermaLink="true">https://6ix.com/company/eckert-and-ziegler-strahlen-und-medizintechnik-ag/news/eckert-and-ziegler-to-participate-in-the-44th-annual-jp-morgan-healthcare-conference</guid>
      <pubDate>Mon, 12 Jan 2026 21:54:30 GMT</pubDate>
      <description>BERLIN - January 12, 2026 (NEWMEDIAWIRE) - Eckert &amp; Ziegler SE (ISIN DE0005659700, TecDAX) will participate in the 44th Annual J.P. Morgan Healthcare Conference on Wednesday, 14 January 2026, at the Westin St. Francis in San Francisco, CA, USA...</description>
    </item>
    <item>
      <title>Nokia expands defense portfolio with two advanced tactical communication solutions</title>
      <link>https://6ix.com/company/eckert-and-ziegler-strahlen-und-medizintechnik-ag/news/nokia-expands-defense-portfolio-with-two-advanced-tactical-communication-solutions-24</link>
      <guid isPermaLink="true">https://6ix.com/company/eckert-and-ziegler-strahlen-und-medizintechnik-ag/news/nokia-expands-defense-portfolio-with-two-advanced-tactical-communication-solutions-24</guid>
      <pubDate>Tue, 09 Sep 2025 07:00:00 GMT</pubDate>
      <description>Nokia Mission-Safe Phone Nokia Mission-Safe Phone Nokia Banshee 5G Tactical Radio Nokia Banshee 5G Tactical Radio Press Release Nokia expands defense portfolio with two advanced tactical communication solutions Introduces Nokia Mission-Safe Phone, a purpose-built defense smartphone for reliable mission-critical communications in the harshest operational environmentsNokia also launches the upgraded Banshee 5G Tactical Radio, a rugged, portable, easy-to-deploy network hub, now with integrated 5G c</description>
    </item>
    <item>
      <title>Annual General Meeting of Eckert &amp; Ziegler SE Approves Dividend of EUR 0.50</title>
      <link>https://6ix.com/company/eckert-and-ziegler-strahlen-und-medizintechnik-ag/news/annual-general-meeting-of-eckert-and-ziegler-se-approves-dividend-of-eur-050</link>
      <guid isPermaLink="true">https://6ix.com/company/eckert-and-ziegler-strahlen-und-medizintechnik-ag/news/annual-general-meeting-of-eckert-and-ziegler-se-approves-dividend-of-eur-050</guid>
      <pubDate>Wed, 18 Jun 2025 20:47:05 GMT</pubDate>
      <description>BERLIN - June 18, 2025 (NEWMEDIAWIRE) - The Annual General Meeting of Eckert &amp; Ziegler SE (ISIN DE0005659700) today approved the proposal of the Executive Board and Supervisory Board and resolved to pay a dividend of EUR 0.50 per share for the...</description>
    </item>
  </channel>
</rss>